263 related articles for article (PubMed ID: 14531817)
1. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure.
Di Iorio BR; Minutolo R; De Nicola L; Bellizzi V; Catapano F; Iodice C; Rubino R; Conte G
Kidney Int; 2003 Nov; 64(5):1822-8. PubMed ID: 14531817
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients.
Feiten SF; Draibe SA; Watanabe R; Duenhas MR; Baxmann AC; Nerbass FB; Cuppari L
Eur J Clin Nutr; 2005 Jan; 59(1):129-36. PubMed ID: 15354199
[TBL] [Abstract][Full Text] [Related]
3. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease.
Bellizzi V; Di Iorio BR; De Nicola L; Minutolo R; Zamboli P; Trucillo P; Catapano F; Cristofano C; Scalfi L; Conte G;
Kidney Int; 2007 Feb; 71(3):245-51. PubMed ID: 17035939
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J
Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100
[TBL] [Abstract][Full Text] [Related]
5. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
6. Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study.
Teplan V; Schück O; Knotek A; Hajný J; Horácková M; Kvapil M;
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S26-30. PubMed ID: 12612947
[TBL] [Abstract][Full Text] [Related]
7. Compliance and effects of nutritional treatment on progression and metabolic disorders of chronic renal failure.
Combe C; Deforges-Lasseur C; Caix J; Pommereau A; Marot D; Aparicio M
Nephrol Dial Transplant; 1993; 8(5):412-8. PubMed ID: 8393545
[TBL] [Abstract][Full Text] [Related]
8. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study.
Teplan V; Schück O; Knotek A; Hajný J; Horácková M; Skibová J; Malý J
Ann Transplant; 2001; 6(1):47-53. PubMed ID: 11803607
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Kidney Int; 2005 Jul; 68(1):246-55. PubMed ID: 15954914
[TBL] [Abstract][Full Text] [Related]
11. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients.
Di Iorio BR; Bellizzi V; Bellasi A; Torraca S; D'Arrigo G; Tripepi G; Zoccali C
Nephrol Dial Transplant; 2013 Mar; 28(3):632-40. PubMed ID: 23166309
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
14. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
Trunzo JA; McHenry CR; Schulak JA; Wilhelm SM
Surgery; 2008 Dec; 144(6):915-8; discussion 919. PubMed ID: 19040997
[TBL] [Abstract][Full Text] [Related]
15. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease.
Marzocco S; Dal Piaz F; Di Micco L; Torraca S; Sirico ML; Tartaglia D; Autore G; Di Iorio B
Blood Purif; 2013; 35(1-3):196-201. PubMed ID: 23485887
[TBL] [Abstract][Full Text] [Related]
16. [Acute and persistent antiproteinuric effect of a low-protein diet in chronic kidney disease].
Di Iorio BR; Cucciniello E; Martino R; Frallicciardi A; Tortoriello R; Struzziero G
G Ital Nefrol; 2009; 26(5):608-15. PubMed ID: 19802806
[TBL] [Abstract][Full Text] [Related]
17. Effect of protein and phosphate restricted and calcium and alphacalcidol supplemented diet on renal and parathyroid functions and protein status in chronic renal failure patients.
Nand N; Aggarwal HK; Anupam ; Sharma M
J Assoc Physicians India; 1999 Sep; 47(9):869-73. PubMed ID: 10778654
[TBL] [Abstract][Full Text] [Related]
18. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.
Williams PS; Stevens ME; Fass G; Irons L; Bone JM
Q J Med; 1991 Oct; 81(294):837-55. PubMed ID: 1801057
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of darbepoetin alpha in hemodialysis patients resistant to human recombinant erythropoietin (rHuEpo).
Hejaili F
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):590-5. PubMed ID: 19587498
[TBL] [Abstract][Full Text] [Related]
20. Body composition of patients on a very low-protein diet: a two-year survey with DEXA.
Chauveau P; Vendrely B; El Haggan W; Barthe N; Rigalleau V; Combe C; Aparicio M
J Ren Nutr; 2003 Oct; 13(4):282-7. PubMed ID: 14566765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
